An updated December 2025 ERS clinical practice guideline provides evidence-based recommendations for managing adult ...

The skin forms a natural barrier that prevents bacteria entering the body. Severe burns stop this protective function from ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. A liver function test checks how ...

Cystic fibrosis treatments are improving patients’ quality of life. Three physicians from University of Iowa Health Care ...

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients ...

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...

Although e-cigarettes are often considered safer than conventional cigarettes, their vapor still poisons lung cells and ...

The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

It is unclear if magnesium sulphate, either alone or combined with other treatments, improves patient outcomes in children under two years old with bronchiolitis. Fu ...

This press release is not intended for UK media HERNEXEOS (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Acceler ...